Gruesome image Zoli. It seems more likely that they just ran out of money during the summer and have just been incapacitated since then. More worrisome to me is the departure of key folks in management. An infusion of cash has an instantaneous effect. It’s harder to quickly restart operations if there is no management team in place. If the cat still survives then it just sits snoozing in its box waiting for a miracle, eg the impact of outside events and forces. What would that miracle look like? Perhaps Chinese pharma progress with the ‘complete vaccine’ and/or cancer vaccine development, maybe even a new partner for the manufacture and distribution of Excellagen. Perhaps even the sale of one or more of its assets to a competitor. I don’t attribute to Joe incompetence, malfeasance or ill will. More likely GNBT has been overtaken by events beyond his control, as often happens with companies operating on the margin. As charitable as this scenario may be, it still amounts to an imploding investment unless a miracle happens. And shareholder litigation? Would I benefit if I shouted at my car because it it had an empty fuel tank? Wasted energy. Perhaps we investors should place our shares (any we decide to keep) in the cat’s box and look elsewhere for opportunity. I don’t doubt that we’ll know if something changes.
Happy and safe 2022 everyone.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links